These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2888052)

  • 21. Estimate of the intrafamilial correlation for serum creatine kinase and pyruvate kinase in females at risk for Duchenne and Becker muscular dystrophies.
    Rabbi-Bortolini E; Dal Colletto GM; Passos-Bueno MR; Vainzof M; Rapaport D; Zatz M
    Hum Hered; 1991; 41(6):370-8. PubMed ID: 1797630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimates of conditional heterozygosity risks for young females in Duchenne muscular dystrophy.
    Passos-Bueno MR; Otto PA; Zata M
    Hum Hered; 1989; 39(4):202-11. PubMed ID: 2583732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum creatine kinase activity and carrier status for duchenne muscular dystrophy.
    Bullock DG; McSweeney FM; Whitehead TP; Edwards JH
    Lancet; 1979 Dec 22-29; 2(8156-8157):1370. PubMed ID: 92710
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum pyruvate-kinase (PK) activity during pregnancy in potential carriers for Duchenne muscular dystrophy.
    Zatz M; Passos MR; Bortolini ER
    Am J Med Genet; 1983 May; 15(1):149-51. PubMed ID: 6859115
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy.
    Zatz M; Rapaport D; Vainzof M; Passos-Bueno MR; Bortolini ER; Pavanello Rde C; Peres CA
    J Neurol Sci; 1991 Apr; 102(2):190-6. PubMed ID: 2072118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Creatine-kinase (CK) and pyruvate-kinase (PK) activities in cord blood of normal newborn infants: application to Duchenne muscular dystrophy screening programs.
    Passos MR; Zatz M
    Am J Med Genet; 1983 Nov; 16(3):367-72. PubMed ID: 6650572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Carrier detection and gene analysis in a Duchenne muscular dystrophy family].
    Lu FM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Aug; 23(4):231-3, 255. PubMed ID: 1979269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase, hemopexin, pyruvate kinase, and lactate dehydrogenase in combination.
    Percy ME; Andrews DF; Thompson MW
    Am J Med Genet; 1982 Sep; 13(1):27-38. PubMed ID: 7137219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High frequency of de novo deletions in Mexican Duchenne and Becker muscular dystrophy patients. Implications for genetic counseling.
    Alcántara MA; Villarreal MT; Del Castillo V; Gutiérrez G; Saldaña Y; Maulen I; Lee R; Macías M; Orozco L
    Clin Genet; 1999 May; 55(5):376-80. PubMed ID: 10422811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A study on the serum biochemistry in carrier detection of Duchenne muscular dystrophy].
    Xie B
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):165-8, 189. PubMed ID: 1889329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of DNA probes in detecting carriers of Duchenne muscular dystrophy: selected case studies.
    Prior TW; Blasco PA; Dove JL; Leshner RT; Gruemer HD
    Clin Chem; 1989 Apr; 35(4):679-83. PubMed ID: 2564818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of carrier status in Duchenne dystrophy by creatine kinase measurement.
    Gruemer HD; Miller WG; Chinchilli VM; Leshner RT; Blasco PA; Hassler CR; Nance WE
    Am J Clin Pathol; 1985 Nov; 84(5):655-8. PubMed ID: 4061390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duchenne muscular dystrophy: comparison among different racial groups.
    Bortolini ER; Zatz M
    Am J Med Genet; 1987 Dec; 28(4):925-9. PubMed ID: 3688030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carrier detection in Duchenne muscular dystrophy: Assessment of the effect of age on detection-rate with serum-creatine-kinase-activity.
    Nicholson GA; Gardner-Medwin D; Pennington RJ; Walton JN
    Lancet; 1979 Mar; 1(8118):692-4. PubMed ID: 85935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyruvate-kinase (PK) and creatine-kinase (CK) in normal pregnancy and its implication in genetic counseling of Duchenne muscular dystrophy (DMD).
    Zatz M; Karp LE; Rogatko A
    Am J Med Genet; 1982 Nov; 13(3):257-62. PubMed ID: 7180871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of DMD carrier status in a family with no known affected males.
    Muntoni F; Mateddu A; Cau M; Congiu R; Puddu R; Cossu P; Cao A; Melis MA
    Dev Med Child Neurol; 1993 Jan; 35(1):70-3. PubMed ID: 8095479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular deletion analysis in Duchenne muscular dystrophy.
    Thomas NS; Ray PN; Worton RG; Harper PS
    J Med Genet; 1986 Dec; 23(6):509-15. PubMed ID: 2879923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of flanking markers in prediction for Duchenne muscular dystrophy.
    Williams H; Sarfarazi M; Brown C; Thomas N; Harper PS
    Arch Dis Child; 1986 Mar; 61(3):218-22. PubMed ID: 3457554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carrier detection in Duchenne muscular dystrophy. Evidence from a study of obligatory carriers and mothers of isolated cases.
    Sibert JR; Harper PS; Thompson RJ; Newcombe RG
    Arch Dis Child; 1979 Jul; 54(7):534-7. PubMed ID: 485196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duchenne muscular dystrophy in a girl with a 45,X/46,XX/47,XXX chromosome constitution.
    Bortolini ER; da Silva DM; Chequer RS; Vianna-Morgante AM; Zatz M
    Am J Med Genet; 1986 Oct; 25(2):239-43. PubMed ID: 3777022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.